# MediWound Ltd. (MDWD)

> MediWound Ltd. (MDWD) trades at $12.90 (-0.54%) as of 5:26:59 PM EST on Nov 13, 2026, +5.65% over the past month. Market cap is $186.64M, with 14.7 days to cover in short interest.

Canonical: https://massive.com/quote/mdwd
Data as of: 2026-11-13T22:26:59.739Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$12.90** -0.07 (-0.54%)
As of 5:26:59 PM EST on Nov 13, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How MediWound Ltd. (MDWD) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.54% |
| 1W | -9.47% |
| 1M | +5.65% |
| YTD | -30.12% |
| 1Y | -29.32% |
| 52-wk range | $11.80 – $19.70 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for MDWD: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $12.77 – $13.23 |
| Open | $13.00 |
| Prev close | $12.97 |
| Volume | 190.28K |
| Market cap | $186.64M |
| Shares out | 13.01M |

## Valuation and profitability ratios

Valuation and profitability ratios for MediWound Ltd.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 333.29 |
| P/B | 7.95 |
| P/FCF | — |
| ROE | -106.7% |
| ROA | -47.7% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 12, 2026

## Insider trading

[MediWound Ltd. (MDWD) insider trading](https://massive.com/quote/mdwd/insider-trading.md): open-market Form 4 buys and sells by MediWound Ltd. insiders over the last 12 months.

## Dividend history and stock splits

MediWound Ltd.'s recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-7 · Dec 20, 2022

## MDWD short interest

How heavily MDWD is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 14.7 |
| Short interest | 1.79M |
| Avg volume | 121.58K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## MDWD news

The latest news and headlines about MediWound Ltd. (MDWD).

- [MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates](https://www.zacks.com/stock/news/3028389/mediwound-mdwd-reports-q3-loss-lags-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3028389) · Zacks Investment Research · Nov 12, 2026 · negative sentiment
- [MediWound Reports Third Quarter 2026 Financial Results and Provides Corporate Update](https://www.globenewswire.com/news-release/2026/11/12/3401377/30505/en/mediwound-reports-third-quarter-2026-financial-results-and-provides-corporate-update.html) · GlobeNewswire Inc. · Nov 12, 2026 · neutral sentiment
- [MediWound (MDWD) Moves 6.1% Higher: Will This Strength Last?](https://www.zacks.com/stock/news/3023811/mediwound-mdwd-moves-6-1-higher-will-this-strength-last?cid=CS-ZC-FT-fundamental_analysis|daily_price_change_5%-3023811) · Zacks Investment Research · Nov 5, 2026 · positive sentiment
- [MediWound to Report First Quarter 2026 Financial Results](https://www.globenewswire.com/news-release/2026/05/07/3289907/30505/en/MediWound-to-Report-First-Quarter-2026-Financial-Results.html) · GlobeNewswire Inc. · May 7, 2026 · positive sentiment
- [MediWound to Present New EscharEx® Data at Leading Wound Care Conferences](https://www.globenewswire.com/news-release/2026/04/07/3268949/30505/en/MediWound-to-Present-New-EscharEx-Data-at-Leading-Wound-Care-Conferences.html) · GlobeNewswire Inc. · Apr 7, 2026 · positive sentiment

## About MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Employees | 121 |
| Listed | Mar 20, 2014 |

[Company website](https://www.mediwound.com)

## FAQ

### What is the MediWound Ltd. (MDWD) stock price today?

MediWound Ltd. (MDWD) is trading at $12.90 (-0.54% on the day) as of 5:26:59 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is MediWound Ltd.?

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and…

### What is the short interest in MDWD?

As of Oct 30, 2026, MDWD has 1.79M shares short and 14.7 days to cover.

### What exchange is MDWD listed on?

MediWound Ltd. (MDWD) trades on Nasdaq in USD.

## Live data

Prices here are 15-minute delayed. For real-time MDWD quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=MDWD`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [MediWound Ltd. (MDWD) insider trading](https://massive.com/quote/mdwd/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms